Relapse of large B-cell lymphoma with IRF4 rearrangement associated with SLAM-associated protein deficiency
- PMID: 37254476
- DOI: 10.1002/pbc.30478
Relapse of large B-cell lymphoma with IRF4 rearrangement associated with SLAM-associated protein deficiency
References
REFERENCES
-
- Au-Yeung RKH, Arias Padilla L, Zimmermann M, et al. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol. 2020;190(5):753-763.
-
- Chisholm KM, Mohlman J, Liew M, et al. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials. Pediatr Blood Cancer. 2019;66(8):e27770.
-
- Ramis-Zaldivar JE, Gonzalez-Farré B, Balagué O, et al. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. Blood. 2020;135(4):274-286.
-
- Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20(2):129-135.
-
- Nichols KE, Hom J, Gong SY, et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med. 2005;11(3):340-345.
Publication types
LinkOut - more resources
Full Text Sources
